Resources & Guides
Educational content about GLP-1 medications, pharmacokinetics, and optimizing your treatment journey.
GLP-1 Medication Hubs
Comprehensive guides for each GLP-1 medication—dosing protocols, clinical trial data, microdosing strategies, and our free calculators.
Semaglutide Guide
Ozempic & Wegovy: GLP-1 receptor agonist. ~15% weight loss, 7-day half-life. FDA-approved for diabetes and weight management.
Tirzepatide Guide
Mounjaro & Zepbound: Dual GLP-1/GIP agonist. ~21% weight loss, 5-day half-life. The first dual-agonist approved by FDA.
Retatrutide Guide
Triple GLP-1/GIP/Glucagon agonist. ~24% weight loss in trials, 6-day half-life. Expected FDA approval 2027.
Educational Content
LillyDirect Mounjaro: Flat $499 Self-Pay Price, Pen Only (2026)
articleWhat Mounjaro actually costs through LillyDirect, why the price does not step up by dose, and how the $25 savings card compares for insured patients.
Zepbound Cost Without Insurance in 2026: Complete Price Guide
articleThe Zepbound KwikPen list price is $1,086.37 a month without insurance. The LillyDirect Self Pay Journey Program (launched February 2026) brings cash-pay vials down to $299 for 2.5mg, $399 for 5mg, and a flat $449 for every dose from 7.5mg to 15mg. This guide covers Zepbound pricing only, with no Mounjaro overlap.
LillyDirect Zepbound: Complete Guide to Self-Pay Vials (2026)
articleEverything you need to know about ordering Zepbound through LillyDirect: pricing by dose tier, eligibility, pharmacy partners, and the 5-step ordering process.
Tirzepatide Cost in 2026: Brand, Vials, and Insurance Guide
articleTirzepatide list price runs over $1,000/month—but what you actually pay can be far less. This guide covers every pricing tier: Mounjaro and Zepbound pens, LillyDirect self-pay vials, insurance and savings cards, Medicare, and where compounded tirzepatide stands after the FDA's 2025 ruling. Includes a cost-per-mg breakdown tied to dose optimisation.